Desjardins, A., Gromeier, M., Friedman, H., Landi, D., Friedman, A., Ashley, D. M., … Bigner, D. (2021). IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In Neuro-Oncology (Vol. 23, pp. vi97–vi97). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab196.385

Desjardins, Annick, Matthias Gromeier, Henry Friedman, Daniel Landi, Allan Friedman, David M. Ashley, William Curry, et al. “IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” In Neuro-Oncology, 23:vi97–vi97. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.385.

Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, et al. IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi97–vi97.

Desjardins, Annick, et al. “IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” Neuro-Oncology, vol. 23, no. Supplement_6, Oxford University Press (OUP), 2021, pp. vi97–vi97. Crossref, doi:10.1093/neuonc/noab196.385.

Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, Curry W, Butowski N, Sloan A, Wen P, Cavaliere R, Gerstner E, Berger M, Buerki R, Chiocca EA, Sauvageau E, Kelly A, Nichols WG, Mixson L, Dickinson A, Orr K, Learn C, Bigner D. IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. Neuro-Oncology. Oxford University Press (OUP); 2021. p. vi97–vi97.